Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer

Status:
Terminated

Trial end date:
2011-05-01

Target enrollment:

Participant gender:

The purpose of this study is to see if IPI-504 in combination with trastuzamab is an effective treatment in HER2 positive metastatic breast cancer

Phase 2

Infinity Pharmaceuticals, Inc.

Trastuzumab